Orasis Pharmaceuticals Announces FDA Approval of QLOSIȒ

/PRNewswire/ -- Orasis Pharmaceuticals, an emerging ophthalmic pharmaceutical company focused on reshaping vision possibilities, today announced that the U.S....

Related Keywords

Kentucky , United States , Japan , Minnesota , Israel , Pikeville , Gina Wesley , Richard Lindstrom , Elad Kedar , Sheri Rowen , Amy Phillips , Paul Smith , Paul Karpecki , Orasis Pharmaceuticals , Sequoia Capital , Drug Administration , Prnewswire Orasis Pharmaceuticals , Kentucky College Of Optometry , Japan Innovation Fund , Kentucky Eye Institute , Linkedin , Nvision Eye Centers , University Of Pikeville , Chief Executive Officer , External Disease , Associate Professor , Kentucky College , Medical Director , Eye Centers , Newport Beach , Full Prescribing Information , Chief Operating Officer , Complete Eye Care , Attending Surgeon Emeritus , Minnesota Eye , Visionary Ventures , Innovation Fund , Bluestem Capital , Lifesci Venture Partners , Maverick Ventures Israel , Important Safety ,